降脂益肝冲剂对非酒精性脂肪性肝病大鼠肝脏TBP-2mRNA表达的影响

目的探讨硫氧还蛋白结合蛋白（TBP-2）与大鼠非酒精性脂肪性肝（NAFLD）的关系,并观察降脂益肝冲剂的疗效,探讨其对肝组织TBP-2mRNA表达的影响。方法72只雄性Wistar大鼠随机分为9组：空白对照组（N组）、实验对照组（M组）,实验干预组（D组）,每组24只,分别设9、13、17周三个时相点。空白对照组给予普通饲料喂养,实验对照组和实验干预组给予高脂饮食喂养。实验干预组分别于0周、9周、13周末开始给予降脂益肝冲剂,同时空白对照组和实验对照组分别给予等量的生活饮用水灌胃,分别于9周、13周、17周末处死各组大鼠。应用半定量逆转录—聚合酶链反应（RT-PCR）法测定各组大鼠肝细胞硫氧还蛋白结合蛋白（TBP-2）mRNA的表达;HE染色观察肝组织病理变化。结果RT-PCR结果发现在单纯性非酒精性脂肪肝期（M1组）TBP-2的mRNA表达（0.63±0.12）较N1组（1.02±0.10）下降明显（P〈0.01）,可能为机体的一种保护性应激,以减少TBP-2对Trx的抑制作用,间接增加了机体的抗氧化能力。当疾病继续进展到非酒精性脂肪性肝炎期（M2组和M3组）,这种保护性应激能力逐渐减少,TBP-2的mRNA表达增加,但仍然少于同期的正常组即空白对照组（N2,N3）（P〈0.01）,提示机体仍可通过下调TBP-2的表达以增加了机体的抗氧化能力;N1,N2,N3组相比TBP-2的mRNA表达统计学上无差异;D2组（0.66±0.79）与M2组（0.89±0.10）,D3组（0.73±0.12）与M3组（0.90±0.88）相比TBP-2的mRNA表达均有所下降（P〈0.01）。药物干预后,肝脏病理改变较实验对照组明显减轻（P〈0.01）。结论TBP-2在单纯性非酒精性脂肪性肝和非酒精性脂肪性肝炎期表达下调,可能是机体的一种保护性应激,参与NAFLD的发生、发展。降脂益肝冲剂对NASLD有很好的防治作用,TBP-2是其可能的作用靶点。

The effect of Jiangzhi Yigan Chongji on TBP-2 mRNA in liver of the rats with nonalclholic fatty liver diseases

Objective To explore the relationship of rat nonalcoholic fatty live（NAFLD） and Thioredoxin-binding protein-2（TBP-2）. To observe the effect of Jiangzhi Yigan Chongji（JYC）on NAFLD rats chronically fed with high-fat diet and explore its effect of expression of TRX -binding protein 2 （TBP-2） mRNA in liver tissue. Methods 72 male Wistar rats were randomly divided into 9 groups（8 rats each group）： blank control group （N）experimental model group（M） and experimental intervention group （D）all of them have three spots 9w、13w、17w.N group fed with with standard diet,M group and D group fed with high-fat diet.The D groups was given JYC by intragastric administration at 0、9、13 weekend,meanwhile,the M and Ngroups were separately given life drinking water by the same means.Then at the end of 9、13、17week,they were put to death. Changes on pathology of liver and hepatocyte TBP-2 expression were observed by hematoxylin and eosin （HE） stain with light microscope and RT-PCR.Results The expression of TBP-2mRNA in liver of every blank control group （N1,N2,N3） kept at similar level without statistical difference（P〉0.05）.The expression of TBP-2mRNA in the liver of M1 group（0.63±0.12） was significantly decreased in comparison with the N1 group（1.02±0.10）（P〈0.01）and increased lightly with the time in the liver of M2 group and M3 group. The expression of TBP-2mRNA in liver of D2 （0.66±0.79）was lower than that in the M2 （0.89±0.10）（P〈0.01）.The expression of TBP-2mRNA in liver of D3 （0.73±0.12）was lower than that in the M3（0.90±0.88）（P〈0.01）. Compared with the M group,the contemporaneous D group shown improvement of the pathology of liver,and with statistical difference （P〈0.01）.Conclusion TBP-2 participate the development of NAFLD and its expression is down-regulation.This is a protective stress for body. JYC have satisfactory therapeutic effects on NAFLD induced with high-fat diet ;and TBP-2 may be the pharmacological therapeut